Simpson Thacher recently represented the underwriters, led by Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC, in connection with a registered offering of $5 billion in notes by Pfizer Inc. The notes were issued in six series with maturities ranging from 2021 to 2048, with proceeds used for general corporate purposes, including to refinance, redeem or repurchase existing debt and to repay a portion of the company’s outstanding commercial paper.
Pfizer is a research-based, global biopharmaceutical company. Pfizer’s global portfolio includes medicines, vaccines and medical devices, as well as many of the world’s best-known consumer healthcare products.
The Simpson Thacher team included Joe Kaufman, Jonathan Ozner, Davis Mahon and Alex Yeagley (Capital Markets); Jon Cantor and Brian Mendick (Tax); Marcela Robledo (Intellectual Property); Jamin Koslowe (Executive Compensation and Employee Benefits); Adeeb Fadil and Noreen Lavan (Environmental); and Jennie Getsin (FINRA and Blue Sky).